Evidence map›Paper›PMID 41032076›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Visual interpretation of [

Huan-Chun Lin, Kuo-Lun Huang, Shih-Hsin Chen, Tsung-Ying Ho, Chin-Chang Huang, Jung-Lung Hsu, Chiung-Chih Chang, Kun-Ju Lin, Ing-Tsung Hsiao

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Huan-Chun LinDepartment of Nuclear Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, TaoYuan, Taiwan.
Kuo-Lun HuangDepartment of Neurology, Linkou Chang Gung Memorial Hospital, TaoYuan, Taiwan.
Shih-Hsin ChenDepartment of Nuclear Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, TaoYuan, Taiwan.
Tsung-Ying HoDepartment of Nuclear Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, TaoYuan, Taiwan.
Chin-Chang HuangDepartment of Neurology, Linkou Chang Gung Memorial Hospital, TaoYuan, Taiwan.
Jung-Lung HsuDepartment of Neurology, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation), New Taipei City, Taiwan.
Chiung-Chih ChangDepartment of Neurology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Kun-Ju LinDepartment of Nuclear Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, TaoYuan, Taiwan. lin4857@adm.cgmh.org.tw.
Ing-Tsung HsiaoDepartment of Nuclear Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, TaoYuan, Taiwan. ihsiao@mail.cgu.edu.tw.ORCID 0000-0002-5255-7498

Funding

Chang Gung Memorial Hospital CMRPD1N0401, BMRP488Chang Gung Memorial Hospital CORPG3P0281, CORPG3P0291, CMRPG3K1093, CORPG3P0021, CORPG3N0011National Science and Technology Council NSTC 113-2314-B-182-042-MY2
6 · The paper itself

Abstract

introductionTau accumulation in the brain is a hallmark of both Alzheimer's disease (AD) and progressive supranuclear palsy (PSP), complicating differential diagnosis. The novel [

methodsEightynine participants of Aβpositive AD, Aβnegative PSP, and cognitively unimpaired controls (CU) underwent [

resultsThe study found significant differences in visual scores between the CU, AD, and PSP groups, particularly in the AD-specific and PSP-specific regions. Visual assessment of tau uptake moderately correlated with SUVr values, especially in AD-specific regions. The decision tree model using visual scores accurately classified CU, AD, and PSP patients, with sensitivity and specificity rates exceeding 85%. Interobserver agreement for visual scoring was high, supporting the reliability of this method in clinical settings.

conclusionVisual interpretation scoring system of [

Indexed as

Alzheimer DiseaseAniline CompoundsCarbolinesImage Interpretation, Computer-AssistedPositron-Emission TomographySupranuclear Palsy, Progressivetau ProteinsAgedAged, 80 and overDiagnosis, DifferentialFemaleHumansMaleMiddle AgedRadiopharmaceuticalsAniline CompoundsCarbolinesRadiopharmaceuticalstau Proteins[18F]FlorzolotauAlzheimer’s diseaseDecision treeProgressive supranuclear palsyTau-PET imagingVisual interpretation

Identifiers

PMID41032076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.